Scott Hiebert, Ph.D.

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

1. BET inhibitors reduce cell size and induce reversible cell cycle arrest in AML. Zhang S, Zhao Y, Heaster TM, Fischer MA, Stengel KR, Zhou X, Ramsey H, Zhou MM, Savona MR, Skala MC, Hiebert SW (2018) J Cell Biochem
   › Primary publication · 30417424 (PubMed) · PMC6513713 (PubMed Central)
2. High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML. Zhao Y, Liu Q, Acharya P, Stengel KR, Sheng Q, Zhou X, Kwak H, Fischer MA, Bradner JE, Strickland SA, Mohan SR, Savona MR, Venters BJ, Zhou MM, Lis JT, Hiebert SW (2016) Cell Rep 16(7): 2003-16
   › Primary publication · 27498870 (PubMed) · PMC4996374 (PubMed Central)
3. Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design. Hargrove TY, Friggeri L, Wawrzak Z, Sivakumaran S, Yazlovitskaya EM, Hiebert SW, Guengerich FP, Waterman MR, Lepesheva GI (2016) J Lipid Res 57(8): 1552-63
   › Primary publication · 27313059 (PubMed) · PMC4959870 (PubMed Central)
4. Myeloid translocation genes differentially regulate colorectal cancer programs. Parang B, Bradley AM, Mittal MK, Short SP, Thompson JJ, Barrett CW, Naik RD, Bilotta AJ, Washington MK, Revetta FL, Smith JJ, Chen X, Wilson KT, Hiebert SW, Williams CS (2016) Oncogene 35(49): 6341-6349
   › Primary publication · 27270437 (PubMed) · PMC5140770 (PubMed Central)
5. Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer. Chan E, Arlinghaus LR, Cardin DB, Goff L, Berlin JD, Parikh A, Abramson RG, Yankeelov TE, Hiebert S, Merchant N, Bhaskara S, Chakravarthy AB (2016) Radiother Oncol 119(2): 312-8
   › Primary publication · 27106554 (PubMed) · PMC4961249 (PubMed Central)
6. Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies. Adams CM, Hiebert SW, Eischen CM (2016) Cancer Res 76(3): 736-48
   › Primary publication · 26676759 (PubMed) · PMC4738141 (PubMed Central)
7. Histone Deacetylase 3 Is Required for Efficient T Cell Development. Stengel KR, Zhao Y, Klus NJ, Kaiser JF, Gordy LE, Joyce S, Hiebert SW, Summers AR (2015) Mol Cell Biol 35(22): 3854-65
   › Primary publication · 26324326 (PubMed) · PMC4609739 (PubMed Central)
8. FOXP3⁺ regulatory T cell development and function require histone/protein deacetylase 3. Wang L, Liu Y, Han R, Beier UH, Bhatti TR, Akimova T, Greene MI, Hiebert SW, Hancock WW (2015) J Clin Invest 125(8): 3304
   › Primary publication · 26237045 (PubMed) · PMC4563765 (PubMed Central)
9. Histone Deacetylase 3 Is Required for T Cell Maturation. Hsu FC, Belmonte PJ, Constans MM, Chen MW, McWilliams DC, Hiebert SW, Shapiro VS (2015) J Immunol 195(4): 1578-90
   › Primary publication · 26163592 (PubMed) · PMC4530026 (PubMed Central)
10. Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells. Dutta P, Sager HB, Stengel KR, Naxerova K, Courties G, Saez B, Silberstein L, Heidt T, Sebas M, Sun Y, Wojtkiewicz G, Feruglio PF, King K, Baker JN, van der Laan AM, Borodovsky A, Fitzgerald K, Hulsmans M, Hoyer F, Iwamoto Y, Vinegoni C, Brown D, Di Carli M, Libby P, Hiebert SW, Scadden DT, Swirski FK, Weissleder R, Nahrendorf M (2015) Cell Stem Cell 16(5): 477-87
    › Primary publication · 25957903 (PubMed) · PMC4426344 (PubMed Central)
11. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3. Wang L, Liu Y, Han R, Beier UH, Bhatti TR, Akimova T, Greene MI, Hiebert SW, Hancock WW (2015) J Clin Invest 125(3): 1111-23
    › Primary publication · 25642770 (PubMed) · PMC4362235 (PubMed Central)
12. Transcriptional corepressor MTG16 regulates small intestinal crypt proliferation and crypt regeneration after radiation-induced injury. Poindexter SV, Reddy VK, Mittal MK, Williams AM, Washington MK, Harris E, Mah A, Hiebert SW, Singh K, Chaturvedi R, Wilson KT, Lund PK, Williams CS (2015) Am J Physiol Gastrointest Liver Physiol 308(6): G562-71
    › Primary publication · 25573176 (PubMed) · PMC4360050 (PubMed Central)
13. The transcriptional corepressor MTGR1 regulates intestinal secretory lineage allocation. Parang B, Rosenblatt D, Williams AD, Washington MK, Revetta F, Short SP, Reddy VK, Hunt A, Shroyer NF, Engel ME, Hiebert SW, Williams CS (2015) FASEB J 29(3): 786-95
    › Primary publication · 25398765 (PubMed) · PMC4763883 (PubMed Central)
14. Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells. Ha K, Fiskus W, Choi DS, Bhaskara S, Cerchietti L, Devaraj SG, Shah B, Sharma S, Chang JC, Melnick AM, Hiebert S, Bhalla KN (2014) Oncotarget 5(14): 5637-50
    › Primary publication · 25026298 (PubMed) · PMC4170637 (PubMed Central)
15. ETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2. Ghosh HS, Ceribelli M, Matos I, Lazarovici A, Bussemaker HJ, Lasorella A, Hiebert SW, Liu K, Staudt LM, Reizis B (2014) J Exp Med 211(8): 1623-35
    › Primary publication · 24980046 (PubMed) · PMC4113936 (PubMed Central)
16. HDAC3 is essential for DNA replication in hematopoietic progenitor cells. Summers AR, Fischer MA, Stengel KR, Zhao Y, Kaiser JF, Wells CE, Hunt A, Bhaskara S, Luzwick JW, Sampathi S, Chen X, Thompson MA, Cortez D, Hiebert SW (2013) J Clin Invest 123(7): 3112-23
    › Primary publication · 23921131 (PubMed) · PMC3696547 (PubMed Central)
17. A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. Hatzi K, Jiang Y, Huang C, Garrett-Bakelman F, Gearhart MD, Giannopoulou EG, Zumbo P, Kirouac K, Bhaskara S, Polo JM, Kormaksson M, MacKerell AD, Xue F, Mason CE, Hiebert SW, Prive GG, Cerchietti L, Bardwell VJ, Elemento O, Melnick A (2013) Cell Rep 4(3): 578-88
    › Primary publication · 23911289 (PubMed) · PMC3854650 (PubMed Central)
18. The transcriptional repressor NKAP is required for the development of iNKT cells. Thapa P, Das J, McWilliams D, Shapiro M, Sundsbak R, Nelson-Holte M, Tangen S, Anderson J, Desiderio S, Hiebert S, Sant'angelo DB, Shapiro VS (2013) Nat Commun : 1582
    › Primary publication · 23481390 (PubMed) · PMC3615467 (PubMed Central)
19. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. Ziesché E, Kettner-Buhrow D, Weber A, Wittwer T, Jurida L, Soelch J, Müller H, Newel D, Kronich P, Schneider H, Dittrich-Breiholz O, Bhaskara S, Hiebert SW, Hottiger MO, Li H, Burstein E, Schmitz ML, Kracht M (2013) Nucleic Acids Res 41(1): 90-109
    › Primary publication · 23087373 (PubMed) · PMC3592411 (PubMed Central)
20. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Chen X, Barozzi I, Termanini A, Prosperini E, Recchiuti A, Dalli J, Mietton F, Matteoli G, Hiebert S, Natoli G (2012) Proc Natl Acad Sci U S A 109(42): E2865-74
    › Primary publication · 22802645 (PubMed) · PMC3479529 (PubMed Central)

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword